Ferring International (Global Rights to LYSTEDA) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Ferring International (Global Rights to LYSTEDA) General Information

Description

Global rights to LYSTEDA (tranexamic acid), non-hormonal therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Ch. de la Vergognausaz 50
  • 1162 Saint-Prex
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Ch. de la Vergognausaz 50
  • 1162 Saint-Prex
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ferring International (Global Rights to LYSTEDA) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ferring International (Global Rights to LYSTEDA)‘s full profile, request access.

Request a free trial

Ferring International (Global Rights to LYSTEDA) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ferring International (Global Rights to LYSTEDA)‘s full profile, request access.

Request a free trial

Ferring International (Global Rights to LYSTEDA) FAQs

  • Where is Ferring International (Global Rights to LYSTEDA) headquartered?

    Ferring International (Global Rights to LYSTEDA) is headquartered in Saint-Prex, Switzerland.

  • What industry is Ferring International (Global Rights to LYSTEDA) in?

    Ferring International (Global Rights to LYSTEDA)’s primary industry is Buildings and Property.

  • Is Ferring International (Global Rights to LYSTEDA) a private or public company?

    Ferring International (Global Rights to LYSTEDA) is a Private company.

  • What is Ferring International (Global Rights to LYSTEDA)’s current revenue?

    The current revenue for Ferring International (Global Rights to LYSTEDA) is .

  • Who are Ferring International (Global Rights to LYSTEDA)’s investors?

    Ferring has invested in Ferring International (Global Rights to LYSTEDA).

  • When was Ferring International (Global Rights to LYSTEDA) acquired?

    Ferring International (Global Rights to LYSTEDA) was acquired on 01-Dec-2020.

  • Who acquired Ferring International (Global Rights to LYSTEDA)?

    Ferring International (Global Rights to LYSTEDA) was acquired by Nordic Pharma (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process